Grindeks Group provides global partners with out-licensing solutions for finished dosage forms, including tablets, capsules, injections and semi-solids.
We offer ready-to-file dossiers and marketing authorization packages suitable for EU and international markets. Our R&D pipeline includes generic and fixed-dose combination products covering major therapeutic areas such as cardiology, neurology, oncology, diabetes, dermatology, and pain management.
Grindeks has extensive experience in pharmaceutical product registration across a wide range of markets. Our company has successfully managed numerous Decentralised Procedures (DCP) and Mutual Recognition Procedures (MRP) within the European Union, consistently ensuring full regulatory compliance and efficient market access.
Beyond the EU, our company has substantial experience in obtaining marketing authorisations in Australia, Canada, Southeast Asia, the Middle East, and CIS countries. Our deep understanding of regional regulatory frameworks enables the development and implementation of effective registration strategies tailored to each specific market.
With comprehensive regulatory knowledge, our company manages every stage of the registration process – from initial planning to final approval – demonstrating excellence and reliability in pharmaceutical registration worldwide.
For collaboration inquiries:
Please reach our Business Development team at [email protected].
